JP MORGAN/CALL/ABBOTT LABORATORIES/130/0.1/20.09.24 Stock

Warrant

DE000JB835G5

Real-time Bid/Ask 07:46:00 2024-06-20 EDT
0.012 EUR / 0.032 EUR +69.23% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/130/0.1/20.09.24
Current month+30.00%
3 months-90.00%
Date Price Change
24-06-19 0.013 +18.18%
24-06-18 0.011 -15.38%
24-06-17 0.013 +30.00%
24-06-14 0.01 -23.08%
24-06-13 0.013 -31.58%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 02:52 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JB835G
ISINDE000JB835G5
Date issued 2023-12-12
Strike 130 $
Maturity 2024-09-20 (92 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.42
Lowest since issue 0.007
Spread 0.02
Spread %62.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
125.4 USD
Spread / Average Target
+20.56%
Consensus